SecurityGSK / GlaxoSmithKline plc
InstitutionLevel Four Advisory Services, Llc
Shares15,937
Value $ 642,000
Related 377372AG2 / Glaxosmithkline Cap Inc. 0.70% 03/18/16
377372AH0 / Glaxosmithkline Cap Inc. 2.80% 03/18/23
377372AJ6 / Glaxosmithkline Cap Inc. 4.20% 03/18/43
377372AA5 / Glaxosmithkline Cap Inc Guaranteed Notes 4.375% 04/15/14
377372AB3 / Glaxosmithkline Cap Inc Guaranteed Notes 5.375% 04/15/34
377373AC9 / Glaxosmithkline Capital 1.50% 05/08/17
377373AD7 / Glaxosmithkline Capital 2.85% 05/08/22
377372AC1 / Glaxosmithkline Capital 4.85% Guaranteed Notes 5/15/13
377372AD9 / Glaxosmithkline Capital 5.65% Guaranteed Notes 5/15/18
377372AE7 / Glaxosmithkline Capital 6.375% Guaranteed Notes 5/15/38
377373AB1 / Glaxosmithkline Capital .75% 05/08/15

Level Four Advisory Services, Llc reports 2.27% increase in ownership of GSK / GlaxoSmithKline plc

August 14, 2018 - Level Four Advisory Services, Llc has filed a 13F-HR form disclosing ownership of 15,937 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $642,000 USD as of June 30, 2018. Level Four Advisory Services, Llc had filed a previous 13F-HR on May 14, 2018 disclosing 15,584 shares of GlaxoSmithKline plc at a value of $609,000 USD. This represents a change in shares of 2.27 percent and a change in value of 5.42 percent during the quarter.

Other investors with positions similar to Level Four Advisory Services, Llc include HighPoint Advisor Group LLC, Salient Trust Co Lta, Compagnie Odier SCA, CENTRAL TRUST Co, P.a.w. Capital Corp, and Cetera Advisor Networks LLC.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 39.68 15,937 2.27 642 5.42 14 19 3.12
2018-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 37.27 15,584 28.83 609 41.96 130 50 11.66
2017-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 38.04 12,097 -56.75 429 -62.24 -604 -103 -9.08
2017-09-30 13F-HR/A-1 GLAXOSMITHKLINE SPONSORED ADR 37733W105 41.27 27,971 53.33 1,136 48.50 402 -31 -4.00
2017-09-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 28,271 1,148
2017-06-30 13F-HR/A-1 GLAXOSMITHKLINE SPONSORED ADR 37733W105 41.94 18,242 -15.54 765 -15.56 -141 -0 -0.03
2017-06-30 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 18,242 765
2017-03-31 13F-HR/A-1 GLAXOSMITHKLINE SPONSORED ADR 37733W105 40.22 21,598 -4.01 906 4.62 -36 76 8.81
2017-03-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 21,598 906
2016-12-31 13F-HR GLAXOSMITHKLINE SPONSORED ADR 37733W105 22,500 866


CUSIP: 37733W105